Top Story

Physician urges FDA not to lift restrictions on drug makers’ claims about their products

July 3, 2015

Drug regulations and a governing body to mandate them is a necessity for patients’ safety and health care providers’ peace-of-mind, according to a recently released commentary in the Annals of Internal Medicine.

“As a prescriber, I have been willing to give up my freedom to prescribe any chemical I choose to patients, and I am willing to have drug manufacturers give up some of their right to tell me whatever they may want me to hear. For all of us (including patients) to hand over some liberties to a Hobbesian Sovereign, such as the FDA, offers a different kind of freedom — knowing that the medications we use are probably, at least as a first approximation, reasonably safe and have some evidence that they work,” Jerry Avorn, MD, Harvard School of Medicine, wrote in his paper.

In the Journals

Radiofrequency ablation safe, effective for medically inoperable NSCLC

July 2, 2015
Radiofrequency ablation conferred 2-year OS rates comparable to stereotactic body radiotherapy in patients with medically inoperable non–small cell lung cancer…
Meeting News Coverage

Clinical trials, health information technology platform to test power of precision medicine

July 2, 2015
CHICAGO — Precision medicine represents a potentially practice-changing advance in the landscape of cancer treatment. Yet, the ability to gather and analyze data…
Drug Pipeline

New collaboration looks to bring potential liver cancer, melanoma drug to China

July 2, 2015
Provectus Biopharmaceuticals, Inc. announced it has signed a Letter of Intent with Boehringer Ingelheim Investment Co. Ltd. in China to collaborate in marketing its…
Ran Reshef, MD In the Journals

Higher CD8 T-cell dose from younger donors improves allogeneic HSCT outcomes

July 2, 2015
A higher graft CD8 dose from younger donors — even if they are not related to the patient — predicted improved survival in patients with hematologic…
More News Headlines »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Meeting News Coverage Video
VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

June 19, 2015
CHICAGO — Vernon K. Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center and a…
More »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
morganatic-roan